Cervical cancer prevention through screening and timely treatment of cervical precancerous lesions has been one of modern medicine’s greatest successes. Current screening recommendations and management guidelines are directed toward the goals of identifying and treating cervical precancer in order to prevent cancer, but also avoiding the untoward consequences of overtreatment. The Practice Improvement in Cervical Screening and Management (PICSM) committee, under the sponsorship of the American Society for Colposcopy and Cervical Pathology (ASCCP), is made up of cervical cancer experts from major scientific and professional society organizations with various health care perspectives. PICSM supports adoption of consensus, evidence-based guidelines developed under the aegis of the ASCCP, the American Cancer Society, the American College of Obstetricians and Gynecologists and others in the field of cervical cancer prevention. In addition, PICSM seeks to highlight areas where current practice may need to be reconsidered based on scientific or clinical advances in the field such as innovations in screening technologies, the introduction of prophylactic HPV vaccines, and improvements in diagnosis and treatment of cervical precancer. As areas to be addressed are identified, PICSM will encourage efforts to bring together appropriate individuals and groups to evaluate current practice and consider the evidence for development of ‘interim guidance’ in advance of revisions to formal Consensus Guidelines.

June 2009 Symposium on Cervical Cancer Screening and Management of Cervical Abnormalities
in Adolescents and Young Women

ACS-ASCCP-ASCP November 2011 Cervical Cancer Screening and Prevention:
The Role of Molecular Testing Symposium

Full Access to this Information is Only Available to ASCCP Members. 

Please Sign in or Join Here.